Helo Corp.OTC: HLOC

Helo Corp. Announces Signing of $88M Letter of Intent with Vyvo Inc.

· Issued by Helo Corp.

San Francisco, California – February 3, 2020 - Helo Corp. (OTC: HLOC) (the “Company”), a leading developer of wearable devices embedded with Life Sensing Technology and dedicated to improving wellness worldwide, today announced that it has signed a  Letter of Intent with Vyvo Inc. to acquire certain strategic assets from Vyvo Inc. so that it can bring the Vyvo business into a public company.

Seán McVeigh, CEO of Helo Corp., said that, “This transaction, which includes the acquisition of assets such as intellectual property, network software, strategic supplier and distribution contracts and debt forgiveness should enable us to quickly transition into the Vyvo business and also improve our balance sheet.  We expect that this agreement will significantly increase our sales revenues as we will capture more of the customer transaction value when customers purchase our wearable devices, and we will also secure additional sales revenues from new products and services. Furthermore, the Company should be able to immediately recognize this additional revenue upon closing.”

Upon closing, Fabio Galdi will be appointed CEO, Alessandro Senatore will be appointed COO and Seán McVeigh will continue as CFO of Helo Corp. Closing of this transaction is subject to the execution of definitive agreements on acceptable terms and the transfer of $88M HLOC shares to the ultimate beneficial owners of Vyvo Inc., namely Fabio Galdi, Alessandro and Seán McVeigh It is also subject to other customary conditions and is expected to occur no later than 30thApril, 2020. There can be no assurance that the acquisition will be completed in the stipulated time or at all.

Fabio Galdi said, “We are extremely excited for the future at Vyvo. As a public company we will have the unique ability to tell our story and access capital in a much more efficient manner. It is an exciting time for us as we will have the technology and expertise all in-house to make a big impact on the $190B worldwide direct selling wellness market. We hope to lead the way in changing how the financial market views direct selling business model by combining our proven technology with Artificial Intelligence (AI) and producing a stream of next generation products that will improve our customer’s wellness.” He continued, “We are delighted with this agreement as it allows us to tie in and consolidate all of Vyvo’s key activities under one company.  The synergies are enormous. From a technology perspective, we can optimise the integration of AI into the Company’s Life Sensing Technology so that we can produce more exciting, customized products that will bring significant and tangible wellness benefits to our customers. Also, our members will benefit financially from this agreement. It gives us the ability to open up new markets in USA, Asia, Europe and Russia, which will generate customer referral commissions for our existing and new members.” Mr Galdi also confirmed that the Company will continue to operate under the HLOC ticker until it can change its name to Vyvo and update its ticker symbol.”

Contact

investors@helocorp.com

+1650-646-2193

About Vyvo Inc.

We are a technology and network marketing company, using technology to create innovative solutions for the personalized health and wellness market worldwide. We are focused on developing consumer-oriented products that protect, monitor and empower people to improve their health through daily knowledge and informed choices. We create customized solutions to help our customers manage their most important asset, themselves and their life.

Our technology driven mission matches our network marketing soul. We are all about expanding concepts of personal growth and development, not only focusing on health but also on prosperity and economic wellbeing. For more information, please see www.vyvo.com.

About Helo Corp..

We are a technology company that provides wearable devices for use in the quantified-self wellness market. Our wearable devices and related applications provide our end-users with health related knowledge acquired through self-tracking. Our Life Sensing Technology uses state-of-the-art sensors, enhanced signal processing and algorithms to collect and process specific data from end-users; and it is embedded into branded wearable devices that are designed, produced and sold into the wellness market through our marketing and distribution partner, Vyvo Pte. Ltd. and its distribution network.  For more information, see www.helocorp.com.

Forward Looking Statement

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," “potential” and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

Company analysis